1070892-92-0

Basic information

• Product Name: 4-chloro-5-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-methoxy-benzoic acid
• Synonyms: 4-chloro-5-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-methoxy-benzoic acid
• CAS NO: 1070892-92-0
• Molecular Weight: 356.688
• Mol File: 1070892-92-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-chloro-5-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-methoxy-benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-chloro-5-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-methoxy-benzoic acid(1070892-92-0)
• EPA Substance Registry System: 4-chloro-5-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-methoxy-benzoic acid(1070892-92-0)

Safety Data

• Hazardous Substances Data: 1070892-92-0(Hazardous Substances Data)

Upstream product

• 749875-16-9 5-bromo-2-(trifluoromethyl)pyridine-4-carboxylic acid 
• 436799-32-5 5-bromo-2(trifluoromethyl)pyridine 
• 1070892-03-3 5-bromo-2-trifluoromethylisonicotinamide 
• 1070892-91-9 4-chloro-5-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-2-methoxy-benzoic acid methyl ester 
• 1070892-04-4 5-bromo-2-trifluoromethylisonicotinonitrile 
• 957066-09-0 5-carboxy-2-chloro-4-methoxy-phenylboronic acid 

Downstream Products

• 1070892-93-1 4-chloro-2-methoxy-5-(6-trifluoromethyl-pyridin-3-yl)-benzoyl chloride 
• 1070892-94-2 4-chloro-5-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-N-(2,6-dimethyl-phenyl)-2-methoxy-benzamide 
• 1070891-28-9 4-chloro-5-(4-cyano-6-trifluoromethyl-pyridin-3-yl)-N-(2,6-dimethyl-phenyl)-2-methoxy-N-methyl-benzamide 

Relevant articles and documents

GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO

GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure, wherein R1a, R1b, R1c, R1d, R2, R2a, and A are as defined herein, including stereoisomers, esters, solvates and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.